Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Magn Reson Med. 2017 Oct 29;79(6):3135–3143. doi: 10.1002/mrm.26976

Figure 1. Upregulated EDB-FN is a marker of breast cancer of high metastatic potential.

Figure 1

a. Analysis of EDB-FN mRNA levels in 4T1 and MDA-MB-231 cells with or without TGFβ treatment. The level of GAPDH was used as an internal control. Data are normalized to the EDB-FN mRNA level of non-treated 4T1 or MDA-MB-231 cells. **: P<0.01, ***: P<0.001 (n=3, two-tailed t-test) compared to non-treated cells. b. Binding of Cy5.5 labeled ZD2 and CREKA peptides on 3D matrigel culture of 4T1 cells. Peptide binding is shown in red.